Effects of Cannabidiol and Beta-Caryophyllene Alone or in Combination in a Mouse Model of Permanent Ischemia
Current treatments for stroke, which account for 6.5 million global deaths annually, remain insufficient for treatment of disability and mortality. One targetable hallmark of stroke is the inflammatory response following infarct, which leads to significant damage post-infarct. Cannabinoids and their...
Main Authors: | Cody G. Yokubaitis, Hassan N. Jessani, Hongbo Li, Allison K. Amodea, Sara Jane Ward |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/6/2866 |
Similar Items
-
Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders
by: Baswan SM, et al.
Published: (2020-12-01) -
Low Doses of β-Caryophyllene Reduced Clinical and Paraclinical Parameters of an Autoimmune Animal Model of Multiple Sclerosis: Investigating the Role of CB<sub>2</sub> Receptors in Inflammation by Lymphocytes and Microglial
by: Vahid Reza Askari, et al.
Published: (2023-07-01) -
Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy
by: Giulia Abate, et al.
Published: (2021-06-01) -
β-Caryophyllene Inhibits Cell Proliferation through a Direct Modulation of CB2 Receptors in Glioblastoma Cells
by: Natasha Irrera, et al.
Published: (2020-04-01) -
β-Caryophyllene Reduces the Inflammatory Phenotype of Periodontal Cells by Targeting CB2 Receptors
by: Giacomo Picciolo, et al.
Published: (2020-06-01)